Luprotas 22.5mg injection consists of the active ingredient Leuprolide acetate. It belongs to the class of medicines called Gonadotropin Releasing Hormone (GnRH) agonists. This injection treats prostate cancer in men, hormone-responsive breast cancer, endometriosis (tissue that usually lines the interior of the uterus grows outside of it), and uterine fibroids (noncancerous growths of the uterus) in women. This medicine is also used for the treatment of premature puberty, which is characterized by early physical development in children due to hormonal imbalances.
Do not receive this injection if you are allergic to Luprotas 22.5mg or its ingredients, including Goserelin and Triptorlin. Before receiving this medicine, inform your physician if you have a liver or kidney impairment. Inform your doctor if you have undiagnosed abnormal uterine bleeding. Do not take this treatment if you are pregnant or planning to get pregnant. During the treatment, the existing symptoms may worsen due to the sex steroid increase in the body. Talk to your physician for more concerns. Report to your doctor if your child has a progressive brain tumor.
Before starting the treatment, notify your doctor about your underlying medical conditions, such as diabetes, seizures, heart problems with chest pain, irregular heartbeats, depression, or are at increased risk of thinning of bones (osteoporosis). This medicine is not recommended for patients with abnormal vaginal bleeding. If you are a woman of childbearing age, use non-hormonal contraceptives while taking Luprotas 22.5mg injection. Report to your doctor if you are a man with urinary obstruction or had an operation to remove your testicles. Tell your doctor if you feel pressure on the spinal cord and experience urinary disorders and haematuria (blood in the urine).
Uses of Luprotas 22.5mg InjectionProstate cancerHormone-responsive breast cancer in perimenopausal (around menopause) womenEndometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus)Central precocious puberty (a child’s body begins to change into an adult too soon caused by a release of certain hormones) Therapeutic Effects of Luprotas 22.5mg Injection
Luprotas 22.5mg decreases testosterone or estrogen production, depending on the treated condition. This helps to slow the growth of cancer cells, reduce the size of uterine fibroids, and alleviate the symptoms of endometriosis and early onset of puberty. Interaction of Luprotas 22.5mg Injection with other drugsInform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional and vitamin supplements, vaccines, and herbal products. Certain medications such as Quinidine, Procainamide, Amiodarone, Sotalol, Pain killers, and Antibiotics may interact with the effects of Luprotas 22.5mg and reduce its effectiveness by causing undesirable side effects. More Information about Luprotas 22.5mg Injection Keep Luprotas 22.5mg out of sight and reach of children.Store in a cool, dry place, away from direct heat and light.Store below 25°CDo not refrigerate or freeze.How to consume Luprotas 22.5mg InjectionLuprotas 22.5mg injection is usually administered in the arm, thigh or abdomen. If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.Safety Advices for Luprotas 22.5mg Injection
Pregnancy
It is unsafe to use Luprotas 22.5mg injection because it is contraindicated in pregnant women. Tell your doctor if you are pregnant or planning to get pregnant before taking this treatment.
Breast Feeding
Luprotas 22.5mg injection is contraindicated in breastfeeding women. Inform your doctor if you are breastfeeding before taking this injection.
Lungs
It is unknown whether Luprotas 22.5mg is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
Liver
Luprotas 22.5mg should be used cautiously in patients with liver impairment. Consult your doctor before receiving it. Notify your doctor about underlying liver conditions.
Alcohol
Consuming alcohol during the Luprotas 22.5mg injection treatment may increase the risk of thinning bones (osteoporosis). Hence caution should be taken. Consult your doctor for more information
Driving
Luprotas 22.5mg injection can cause drowsiness, visual disturbances, or dizziness. It is unsafe; hence avoid driving if you are unwell.
Side Effects of Luprotas 22.5mg InjectionSide effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.Serious
- Severe rash, itching
- Shortness or difficulty of breath
- Cough with blood
- Pulmonary embolism
- Severe headache
Common
- Altered blood sugar and cholesterol levels
- Injection site reactions
- Loss of appetite
- Abnormal liver function
- Swelling in the ankle or hand
- Difficulty sleeping, headache
- Mood swings, depression
- Weight changes
- Nausea, vomiting
- Vaginal dryness, bleeding
- Loss of interest in sexual intercourse
- Hot flushes
- Bone pain, muscle weakness
- Breast tenderness
Word of AdviceDuring the treatment of breast cancer with Luprotas 22.5mg, it is recommended to undergo regular checkups every three months in combination with an aromatase inhibitor. Do not receive this injection if you experience any abnormal vaginal bleeding. Consult your doctor immediately if you or your child is suffering from a headache even after treating it with pain killer, vision problems, buzzing, or ringing in the ear. If you have diabetes, ask your doctor to monitor your glucose and blood sugar levels regularly. Before starting, inform your doctor if you are still mensurating. FAQs Q 1. How does Luprotas 22.5mg work? Luprotas 22.5mg decreases testosterone or estrogen production, depending on the treated condition. This helps to slow the growth of cancer cells, reduce the size of uterine fibroids, and alleviate the symptoms of endometriosis and early onset of puberty.
Q 2. Who should not use Luprotas 22.5mg?Luprotas 22.5mg should not be used by pregnant and breastfeeding women, people who are allergic to the medication, or people with a history of osteoporosis or bone fractures. It should also be used cautiously in people with a past of depression or mental illness.
Q 3. What should I do if I miss a dose of Luprotas 22.5mg? If you miss a dose of Luprotas 22.5mg, contact your healthcare provider as soon as possible to schedule the missed dose. Do not double up on doses to make up for a missed one.
Q 4. Can Luprotas 22.5mg cause weight gain? Weight gain is not a common side effect of Luprotas 22.5mg, but it may occur in some people.
Q 5. How does Luprotas 22.5mg help with endometriosis? Endometriosis is a condition where the tissue that lines the uterus grows outside of it, which can cause pain and other symptoms. Luprotas 22.5mg decreases estrogen production, contributing to endometriosis tissue growth. By reducing estrogen levels, Luprotas 22.5mg can help alleviate the symptoms of endometriosis.
Fact Box of Luprotas 22.5mg InjectionMolecule name: Leuprolide acetate | Therapeutic class: Antineoplastics |
Pharmacological class: Gonadotropin-Releasing Hormone (GnRH) agonists | Indication: 1. Prostate cancer 2. Hormone-responsive breast cancer in perimenopausal (around menopause) women 3. Endometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus) 4. Central precocious puberty (a child’s body begins to change into an adult too soon caused by a release of certain hormones) |
